Kaptopril Krka

Captopril, the active ingredient in Kaptopril Krka, is an ACE inhibitor presented as an oral dosage form for oral use therapy. It lowers elevated blood pressure and improves cardiac function in patients with hypertension, heart failure, diabetic kidney disease, and after myocardial infarction.\n\nGNH India supplies Kaptopril Krka as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company emphasizes quality assurance, regulatory compliance and reliable logistics across multiple regions to meet the needs of healthcare providers.

Captopril acts on the renin‑angiotensin‑aldosterone system to control blood pressure and cardiac workload.\n\n- Hypertension: reduces systemic arterial pressure, decreasing cardiovascular risk.\n- Congestive heart failure: improves ventricular function and reduces fluid overload.\n- Diabetic nephropathy: slows progression of renal impairment in diabetic patients.\n- Post‑myocardial infarction: lowers the risk of recurrent cardiac events and improves survival.

Captopril may cause a range of adverse reactions, varying from mild to serious.\n\nCommon Side Effects:\n- Dry cough: persistent, non‑productive cough.\n- Dizziness: especially upon standing.\n- Headache: mild to moderate intensity.\n- Taste disturbances: metallic or altered taste perception.\n\nSerious or Rare Side Effects:\n- Angioedema: swelling of face, lips, tongue, potentially airway‑obstructing.\n- Severe hypotension: marked drop in blood pressure, causing faintness.\n- Neutropenia: significant reduction in neutrophil count, increasing infection risk.

When prescribing Captopril, clinicians should consider several precautionary measures to ensure patient safety.\n\n- Renal function: assess baseline creatinine and monitor regularly.\n- Electrolytes: monitor potassium levels to avoid hyper‑ or hypokalemia.\n- Pregnancy: avoid use unless benefits outweigh potential risks.\n- Concurrent diuretics: watch for excessive blood pressure reduction.\n- Store at ambient temperature: keep in original container, protect from moisture and light.

Captopril can interact with other medicines, altering its efficacy or safety profile.\n\nMajor Interactions (Avoid):\n- Aliskiren: combined use may cause excessive hypotension and renal impairment.\n- Potassium‑sparing diuretics or supplements: increase risk of hyperkalemia.\n\nModerate Interactions (Monitor Closely):\n- NSAIDs: may blunt antihypertensive effect and affect renal function.\n- Lithium: Captopril may raise lithium concentrations, requiring level monitoring.\n- Beta‑blockers: additive blood pressure‑lowering effect; monitor for symptomatic hypotension.